Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Abstract

Losartan conferred significant renal benefits in patients with type 2 diabetes and nephropathy, and it was generally well tolerated.

Keywords

MedicineLosartanInternal medicineDiabetic nephropathyNephropathyDiabetes mellitusType 2 diabetesCreatinineKidney diseaseBlood pressureProteinuriaUrologyRenal functionEndocrinologyAngiotensin IIGastroenterologyKidney

Affiliated Institutions

Related Publications

Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease

Wan‐Chuan Tsai , Hon‐Yen Wu , Yu‐Sen Peng +9 more

Targeting BP below the current standard did not provide additional benefit for renal outcomes compared with standard treatment during a follow-up of 3.3 years in patients with C...

2017 JAMA Internal Medicine 137 citations

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Carlos M. Ferrario , Jewell A. Jessup , Mark C. Chappell +5 more

Background— Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by converting angiotensin II (Ang II) into the vaso...

2005 Circulation 1598 citations

Prevalence of Complications Among Second-Generation Japanese-American Men With Diabetes, Impaired Glucose Tolerance, or Normal Glucose Tolerance

Wilfred Y. Fujimoto , Donna L. Leonetti , James L. Kinyoun +3 more

In a study sample of 229 second-generation Japanese- American (Nisei) men, 79 with normal glucose tolerance, 72 with impaired glucose tolerance (IGT), and 78 with non-insulin-de...

1987 Diabetes 128 citations

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic , Meg Jardine , Bruce Neal +21 more

In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...

2019 New England Journal of Medicine 5513 citations

Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment

Sreekumar Raghavakaimal , Panagiotis Halvatsiotis , Jill Coenen Schimke +1 more

Type 2 diabetes is characterized by muscle insulin resistance. Nondiabetic first-degree relatives of type 2 diabetic patients have also been reported to have insulin resistance....

2002 Diabetes 256 citations

Publication Info

Year: 2001
Type: article
Volume: 345
Issue: 12
Pages: 861-869
Citations: 7351
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

7351

OpenAlex

Cite This

APA Style

                            
                                
                                    Barry M. Brenner, 
                                
                                    Mark E. Cooper, 
                                
                                    Dick de Zeeuw
                                
                                et al.
                            
                            (2001). 
                            Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. 
                            New England Journal of Medicine
                            , 345
                            (12)
                            , 861-869.
                            https://doi.org/10.1056/nejmoa011161
                        

Identifiers

DOI: 10.1056/nejmoa011161